AzTrials
AzTrials

HypospadiasNCT07006922

Can a Platelet-Rich Plasma Covering Layer Reduce Urethrocutaneous Fistula Rate After Distal Penile Hypospadias Repair Using the STAR Technique: A Randomized Controlled Trial

A study testing hypospadias repair using the STAR technique with PRP as protective layer and hypospadias repair using the STAR technique in people with Hypospadias and Pediatric Urology, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Methods We conducted a prospective randomized controlled study at the Pediatric Urology Department of Cairo University Specialized Pediatric Hospital between July 2024 and January 2025 . The study included boys undergoing primary repair of distal penile hypospadias. Read more about this study

Who is it for?
Ages 6 months to 14 years, men only
Conditions the study is for
Hypospadias, Pediatric Urology
What is being tested?
hypospadias repair using the STAR technique with PRP as protective layer and hypospadias repair using the STAR technique
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
1 siteEgypt
Study dates
1 Jul 2024to 1 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 14 years
  • Men only
  • No healthy volunteers
  • Child

Who may be able to join

  • Pediatric patients with distal penile hypospadias, primary or fresh cases will be selected and circumcised or uncircumcised are included

Who cannot join

  • Pediatric patients with other types of hypospadias, distal penile hypospadias who has history of previous surgical trail

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Giza, 02

Other trials in Egypt

About this study

Methods We conducted a prospective randomized controlled study at the Pediatric Urology Department of Cairo University Specialized Pediatric Hospital between July 2024 and January 2025 . The study included boys undergoing primary repair of distal penile hypospadias. Ethical approval was obtained from the institution's review board, and informed consent was secured from the parents or legal guardians of all participants.

The study included distal penile hypospadias (glandular, coronal, or subcoronal meatus). Exclusion criteria were: proximal or mid-penile hypospadias, any history of prior hypospadias repair, bleeding or coagulation disorders and other significant genitourinary anomalies.

Read more

The participants were randomly allocated into two equal groups using simple randomization (sealed envelope method). Group A (PRP group) underwent repair with the STAR technique plus an intermediate PRP covering layer. Group B (Control group) underwent repair using the same technique but without PRP. All surgeries were performed by the same pediatric urologist, an experienced surgeon in hypospadias repair, to eliminate inter-surgeon variability.

All patients were operated on under general anesthesia with caudal block analgesia. A standard STAR hypospadias repair was carried out in each case as described by Seleim (10). In brief, the STAR technique involves anatomical reassembly of penile tissues guided by the topography of the glans and corpus spongiosum (the exclusive zipping-up of the unfolded spongiosal plate). A fine-tipped tenotomy scissor used for dissection, starting at the apex of the hypoplastic "V" and extending into the ventral edges of the hooded prepuce on each side, following the demarcation lines. Then, a midline cutting back of the ventral hypoplastic urothelial sheet from the hypospadias meatus to the point of spongiosal bifurcation was made . Excision of the hypoplastic skin ridge all the way from the point of bifurcation till each ipsilateral ventral endpoint of the glanular meatal marks to maximize the epithelialized endoluminal surface of the newly zipped-up spongiosal plate. An interrupted single -layedred spongioplasty ( zipper closure) using 6/0 Vicryl Absorbable sutures (13mm needle, Ethicon Inc, Somerville, New Jersey) is applied over a naeleton catheter . Lastly, the glansplasty is done using 3 slanting sutures. In Group A, before skin closure, a PRP layer was applied over the neourethra, whereas in Group B the repair proceeded directly to skin closure without PRP.

PRP Preparation and Application In Group A patients, approximately 5-10 mL of the child's blood was drawn from a peripheral vein at the start of the operation. The blood was collected into a sterile tube without anticoagulant additives and immediately centrifuged at ~3000 rpm for 20 minutes. This process separated the blood into three components: an upper platelet-poor plasma, a middle platelet-rich plasma, and a bottom red blood cell layer. The platelet-rich plasma fraction was then isolated. After the neourethra was constructed and prior to skin closure, the PRP was applied directly as a liquid/gel onto the repair site covering the neourethra. In a few minutes, PRP forms a clot-like gel layer. No additional dartos or fascia flaps were used in either group, in keeping with the STAR technique's usual practice.

Postoperative Care and Follow-up All patients had a compressive dressing applied, which was removed on the third postoperative day. A urethral stent catheter was left in place to divert urine; this was kept for 7 days postoperatively. Broad-spectrum prophylactic antibiotics were given while the catheter was in situ. Parents were instructed on catheter care and advised to ensure the child avoided straddling activities.

After catheter removal, the urinary stream was observed to ensure it was not deviated or weak. Patients were followed up weekly for at least 4 weeks after surgery, and then monthly up to 3 months. At each follow-up visit, the penis was examined for any complications including urethrocutaneous fistula, meatal stenosis, wound infection, glans dehiscence, and persistent edema or flap necrosis.

Cosmetic and functional outcomes were evaluated at the 1-month visit and again at 3 months using the HOSE score, which assigns points for meatal location, meatal shape, urinary stream, erection straightness, and overall appearance. A higher HOSE score (maximum 16) indicates a more favorable outcome.

Outcome Measures The primary outcome measure was the occurrence of urethrocutaneous fistula within the follow-up period. Key secondary outcomes included incidence of other complications (edema, infection, meatal stenosis, glans dehiscence), the operative time (skin-to-skin surgical duration in minutes), and the cosmetic outcome (HOSE score and meatal configuration).

Statistical Analysis Data were analyzed using the statistics software, SPSS software (IBM SPSS, v25). Continuous variables like age and operative time were not normall

Being tested
hypospadias repair using the STAR technique with PRP as protective layer, hypospadias repair using the STAR technique
Keywords
Platelet-Rich Plasma, Hypospadias Repair, Urethrocutaneous Fistula, Pediatric Urology., STAR Technique
Medical subject headings
Hypospadias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • hypospadias repair using the STAR technique with PRP as protective layerProcedure or surgery

    the STAR technique involves anatomical reassembly of penile tissues guided by the topography of the glans and corpus spongiosum (the exclusive zipping-up of the unfolded spongiosal plate). A fine-tipped tenotomy scissor used for dissection, starting at the apex of the hypoplastic "V" and extending into the ventral edges of the hooded prepuce on each side, following the demarcation lines. Then, a midline cutting back of the ventral hypoplastic urothelial sheet from the hypospadias meatus to the point of spongiosal bifurcation was made . Excision of the hypoplastic skin ridge all the way from the point of bifurcation till each ipsilateral ventral endpoint of the glanular meatal marks to maximize the epithelialized endoluminal surface of the newly zipped-up spongiosal plate. An interrupted single -layedred spongioplasty ( zipper closure) using 6/0 Vicryl Absorbable sutures (13mm needle, Ethicon Inc, Somerville, New Jersey) is applied over a naeleton catheter . Lastly, the glansplasty is d

  • hypospadias repair using the STAR techniqueProcedure or surgery

    the STAR technique involves anatomical reassembly of penile tissues guided by the topography of the glans and corpus spongiosum (the exclusive zipping-up of the unfolded spongiosal plate). A fine-tipped tenotomy scissor used for dissection, starting at the apex of the hypoplastic "V" and extending into the ventral edges of the hooded prepuce on each side, following the demarcation lines. Then, a midline cutting back of the ventral hypoplastic urothelial sheet from the hypospadias meatus to the point of spongiosal bifurcation was made . Excision of the hypoplastic skin ridge all the way from the point of bifurcation till each ipsilateral ventral endpoint of the glanular meatal marks to maximize the epithelialized endoluminal surface of the newly zipped-up spongiosal plate. An interrupted single -layedred spongioplasty ( zipper closure) using 6/0 Vicryl Absorbable sutures (13mm needle, Ethicon Inc, Somerville, New Jersey) is applied over a naeleton catheter . Lastly, the glansplasty is d

Study groups in NCT07006922
Study groupRoleWhat they receive
STAR+ PRPExperimentalunderwent repair using the STAR technique with an additional PRP layer over the neourethra
Receives: Procedure: hypospadias repair using the STAR technique with PRP as protective layer
STAR onlyExperimentalreceived the STAR repair without PRP
Receives: Procedure: hypospadias repair using the STAR technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. urethrocutaneous fistula

    Measured: 4 weeks

Secondary outcomes (1)
  1. postoperative complications (edema, infection, meatal stenosis), operative time, and cosmetic outcome using the Hypospadias Objective Scoring Evaluation (HOSE).

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2025
  2. Study start1 Jul 2024
  3. Primary completion1 Jan 2025
  4. Study completion1 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07006922
Sponsor's protocol ID
MS*225-2024
Status last verified
Jul 2024
First submitted
28 May 2025
Last updated
5 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing hypospadias repair using the STAR technique with PRP as protective layer and hypospadias repair using the STAR technique in people with Hypospadias and Pediatric Urology, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

urethrocutaneous fistula (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in